Abstract
Stroke is the leading cause of disability in developed countries, and investigations to identify ways to recover lost neurological function continue. The potential of stem cell therapy could be enormous, but current knowledge and techniques remain limited. In this review article, findings related to the therapeutic potential of acceleration of endogenous neurogenesis and neuronal stem cell transplantation are introduced. The therapeutic effects of acceleration of endogenous neurogenesis have been shown to be mild, but they improve neurological function significantly, and clinical trials are ongoing. In contrast, the potential of neural stem cell transplantation has been reported in many basic experiments, but current basic knowledge and techniques are likely to be insufficient to proceed to clinical trials. The possible missing elements for successful neuronal stem cell transplantation in patients with cerebral infarction are discussed.
Keywords: angiogenesis, cell therapy, cerebral infarction, clinical trial, neural stem cells, neurogenesis, stroke, subventricular zone, vascular endothelial growth factor, granulocyte colony-stimulating factor, brain-derived neurotrophic factor, erythropoietin, endothelial stem/progenitor cell, embolic stem cell, induced pluripotent stem cell, CD34-positive cell, bone marrow mononuclear cell, T-lymphocyte, CD4-positive lymphocyte, CD8-positive lymphocyte, mesenchymal cell, inflammation, apoptotic cell death, immune system, therapeutic time window
Current Signal Transduction Therapy
Title: The Therapeutic Potential of Neural Stem Cells in Cerebral Ischemia
Volume: 6 Issue: 3
Author(s): Yukiko Kasahara, Takayuki Nakagomi, Akiko Nakano-Doi, Tomohiro Matsuyama and Akihiko Taguchi
Affiliation:
Keywords: angiogenesis, cell therapy, cerebral infarction, clinical trial, neural stem cells, neurogenesis, stroke, subventricular zone, vascular endothelial growth factor, granulocyte colony-stimulating factor, brain-derived neurotrophic factor, erythropoietin, endothelial stem/progenitor cell, embolic stem cell, induced pluripotent stem cell, CD34-positive cell, bone marrow mononuclear cell, T-lymphocyte, CD4-positive lymphocyte, CD8-positive lymphocyte, mesenchymal cell, inflammation, apoptotic cell death, immune system, therapeutic time window
Abstract: Stroke is the leading cause of disability in developed countries, and investigations to identify ways to recover lost neurological function continue. The potential of stem cell therapy could be enormous, but current knowledge and techniques remain limited. In this review article, findings related to the therapeutic potential of acceleration of endogenous neurogenesis and neuronal stem cell transplantation are introduced. The therapeutic effects of acceleration of endogenous neurogenesis have been shown to be mild, but they improve neurological function significantly, and clinical trials are ongoing. In contrast, the potential of neural stem cell transplantation has been reported in many basic experiments, but current basic knowledge and techniques are likely to be insufficient to proceed to clinical trials. The possible missing elements for successful neuronal stem cell transplantation in patients with cerebral infarction are discussed.
Export Options
About this article
Cite this article as:
Kasahara Yukiko, Nakagomi Takayuki, Nakano-Doi Akiko, Matsuyama Tomohiro and Taguchi Akihiko, The Therapeutic Potential of Neural Stem Cells in Cerebral Ischemia, Current Signal Transduction Therapy 2011; 6 (3) . https://dx.doi.org/10.2174/157436211797484038
DOI https://dx.doi.org/10.2174/157436211797484038 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Effect of GLP-1 Based Therapies on Diabetic Dyslipidemia
Current Diabetes Reviews Second-Generation Antipsychotic Agents: A Review of Safety Profiles
Current Psychiatry Reviews Novel Therapeutic Strategy in the Management of COPD: A Systems Medicine Approach
Current Medicinal Chemistry Clinical Applications of Nanotechnology in Atherosclerotic Diseases
Current Nanoscience Risk Reduction and Prevention of Alzheimer's Disease: Biological Mechanisms of Diet
Current Alzheimer Research Vasospastic Angina and Ca Channel Blockers
Current Hypertension Reviews Determination of Selenium in Eggs of Different Birds Using Sample Digestion in a Reflux System and Hydride Generation Atomic Fluorescence Spectrometry
Current Analytical Chemistry Apoptosis: Potential Therapeutic Targets for New Drug Discovery
Current Medicinal Chemistry Technological Innovations in Magnetic Resonance for Early Detection of Cardiovascular Diseases
Current Pharmaceutical Design Association of Selected Adipocytokines and Inflammatory Markers on Body Mass Index in Type 2 Diabetes Patients in Saudi Arabia and as Risk Factors to Cardiovascular Disease
Current Diabetes Reviews Thyroid Hormone Ligands and Metabolic Diseases
Current Pharmaceutical Design Role of C-Reactive Protein in Acute Myocardial Infarction and Stroke: Possible Therapeutic Approaches
Current Pharmaceutical Biotechnology Morbidity and Mortality Associated with Pharmacotherapy. Evolution and Current Concept of Drug-Related Problems
Current Pharmaceutical Design Premature Ovarian Insufficiency and Long-Term Health Consequences
Current Vascular Pharmacology Role of Thrombin Activatable Fibrinolysis Inhibitor in Endocrine and Cardiovascular Disorders: An Update
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Metabolic Syndrome, Thyroid Function and Autoimmunity - The PORMETS Study
Endocrine, Metabolic & Immune Disorders - Drug Targets Cardioprotective Effect of Resveratrol and Resveratroloside
Cardiovascular & Hematological Agents in Medicinal Chemistry Drugs of Abuse: Epigenetic Mechanisms in Toxicity and Addiction
Current Medicinal Chemistry Relationship between Hyperlipidemia, Cardiovascular Disease and Stroke: A Systematic Review
Current Cardiology Reviews Cardiotoxicity of Molecularly Targeted Agents
Current Cardiology Reviews